000 01453 a2200397 4500
005 20250515202605.0
264 0 _c20100303
008 201003s 0 0 eng d
022 _a2040-2066
024 7 _a10.3851/IMP1460
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHolcakova, Jitka
245 0 0 _aThe inhibitor of cyclin-dependent kinases, olomoucine II, exhibits potent antiviral properties.
_h[electronic resource]
260 _bAntiviral chemistry & chemotherapy
_cJan 2010
300 _a133-42 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntiviral Agents
_xpharmacology
650 0 4 _aCyclin-Dependent Kinases
_xantagonists & inhibitors
650 0 4 _aHumans
650 0 4 _aInhibitory Concentration 50
650 0 4 _aProtein Kinase Inhibitors
_xpharmacology
650 0 4 _aPurines
_xpharmacology
650 0 4 _aVirus Physiological Phenomena
_xdrug effects
650 0 4 _aVirus Replication
_xdrug effects
650 0 4 _aViruses
_xenzymology
700 1 _aTomasec, Peter
700 1 _aBugert, Joachim J
700 1 _aWang, Eddie Cy
700 1 _aWilkinson, Gavin Wg
700 1 _aHrstka, Roman
700 1 _aKrystof, Vladimir
700 1 _aStrnad, Miroslav
700 1 _aVojtesek, Borivoj
773 0 _tAntiviral chemistry & chemotherapy
_gvol. 20
_gno. 3
_gp. 133-42
856 4 0 _uhttps://doi.org/10.3851/IMP1460
_zAvailable from publisher's website
999 _c19433212
_d19433212